Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OLIG2 Antikörper (AA 1-141)

Der Maus Monoklonal Anti-OLIG2-Antikörper wurde für IHC (f) validiert. Er ist geeignet, OLIG2 in Proben von Human zu detektieren.
Produktnummer ABIN6939031

Kurzübersicht für OLIG2 Antikörper (AA 1-141) (ABIN6939031)

Target

Alle OLIG2 Antikörper anzeigen
OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Reaktivität

  • 81
  • 44
  • 41
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 73
  • 23
  • 1
Maus

Klonalität

  • 64
  • 33
Monoklonal

Konjugat

  • 54
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser OLIG2 Antikörper ist unkonjugiert

Applikation

  • 53
  • 40
  • 35
  • 18
  • 15
  • 13
  • 13
  • 11
  • 11
  • 9
  • 8
  • 4
  • 3
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

OLIG2-2400
  • Bindungsspezifität

    • 16
    • 12
    • 9
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-141

    Spezifität

    Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis).

    Kreuzreaktivität (Details)

    Human,

    Aufreinigung

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)

    Isotyp

    IgG1
  • Applikationshinweise

    Positive Control: THP-1 cells. Astrocytoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.

    Haltbarkeit

    24 months
  • Target

    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

    Andere Bezeichnung

    OLIG2

    Hintergrund

    Basic helix loop helix protein class B1 (bHLHB1), basic helix-loop-helix protein 19 (bHLHe19), OLIG2, Oligodendrocyte lineage transcription factor 2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, Protein kinase C-binding protein 2 (PRKCBP2), RACK17,OLIG2 (Marker of Glial Brain Tumors)
    Cellular localisation: Nuclear

    Molekulargewicht

    30-40kDa

    Gen-ID

    10215, 176977

    UniProt

    Q13516
Sie sind hier:
Chat with us!